Tenon Medical, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Tenon Medical, Inc. (TNON) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 752.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 19.74M shares, a 183.68% increase year-over-year.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.96M shares, a 1036.37% increase year-over-year.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 612.50K shares, a 157.96% increase year-over-year.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 237.44K shares, a 94.59% decline year-over-year.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 10.93M shares, a 198.96% increase from fiscal 2024.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.66M shares, a 1288.53% increase from fiscal 2023.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 263.33K shares, a 13.82% increase from fiscal 2022.
- Tenon Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 231.35K shares, a 94.69% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 752.32K shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 19.74M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 10.93M shares 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | 7.44M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 220.53K shares 10-Q · filed 2026-08-13 | 7.72M shares 10-Q · filed 2025-08-13 | ||||||
| 2025-03-31 | 6.96M shares 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | 3.66M shares 10-K · filed 2026-03-27 | 3.57M shares 10-K · filed 2025-03-26 | ||||||
| 2024-09-30 | 3.65M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 612.50K shares 10-Q · filed 2025-08-13 | 5.22M shares 10-Q · filed 2024-08-13 | ||||||
| 2024-03-31 | 612.50K shares 10-Q · filed 2025-05-13 | 5.19M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 263.33K shares 10-K · filed 2025-03-26 | 2.11M shares 10-K · filed 2024-03-29 | ||||||
| 2023-09-30 | 275.61K shares 10-Q · filed 2024-11-14 | 2.20M shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 2.20M shares 10-Q · filed 2024-08-13 | 22.00M shares 10-Q · filed 2023-08-11 | ||||||
| 2023-03-31 | 237.44K shares 10-Q · filed 2024-05-15 | 2.37M shares 10-Q · filed 2023-05-09 | ||||||
| 2022-12-31 | 231.35K shares 10-K · filed 2024-03-29 | 2.31M shares 10-K · filed 2023-03-10 | ||||||
| 2022-09-30 | 228.09K shares 10-Q · filed 2023-11-14 | 2.28M shares 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | 1.97M shares 10-Q · filed 2023-08-11 | |||||||
| 2022-03-31 | 4.39M shares 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | 4.35M shares 10-K · filed 2023-03-10 | |||||||
| 2021-09-30 | 3.06M shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 2.83M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |